Sherman KE - Search Results

1

Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients.

Sherman KE, Shire NJ, Rouster SD, Peters MG, James Koziel M, Chung RT, Horn PS. Sherman KE, et al. Gastroenterology. 2005 Feb;128(2):313-27. doi: 10.1053/j.gastro.2004.11.059. Gastroenterology. 2005. PMID: 15685543 Free PMC article. Clinical Trial.

2

Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group.

Sherman KE, Rouster SD, Chung RT, Rajicic N. Sherman KE, et al. Clin Infect Dis. 2002 Mar 15;34(6):831-7. doi: 10.1086/339042. Epub 2002 Feb 6. Clin Infect Dis. 2002. PMID: 11833007

3

Comparison of methodologies for quantification of hepatitis C virus (HCV) RNA in patients coinfected with HCV and human immunodeficiency virus.

Sherman KE, Rouster SD, Horn PS. Sherman KE, et al. Clin Infect Dis. 2002 Aug 15;35(4):482-7. doi: 10.1086/341976. Epub 2002 Jul 22. Clin Infect Dis. 2002. PMID: 12145734

4

Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects.

Chung RT, Evans SR, Yang Y, Theodore D, Valdez H, Clark R, Shikuma C, Nevin T, Sherman KE; AIDS Clinical Trials Group 383 Study Team. Chung RT, et al. Among authors: sherman ke. AIDS. 2002 Sep 27;16(14):1915-23. doi: 10.1097/00002030-200209270-00008. AIDS. 2002. PMID: 12351951

5

Intrafamilial transmission of hepatitis C virus in patients with hepatitis C and human immunodeficiency virus coinfection.

Keiserman DR, Both CT, Mattos AA, Remiao J, Alexandre CO, Sherman KE. Keiserman DR, et al. Among authors: sherman ke. Am J Gastroenterol. 2003 Apr;98(4):878-83. doi: 10.1111/j.1572-0241.2003.07340.x. Am J Gastroenterol. 2003. PMID: 12738471

6

Implications of peginterferon use in special populations infected with HCV.

Sherman KE. Sherman KE. Semin Liver Dis. 2003;23 Suppl 1:47-52. doi: 10.1055/s-2003-41634. Semin Liver Dis. 2003. PMID: 12934168 Review.

7

Hepatitis C virus (HCV) diversity in HIV-HCV-coinfected subjects initiating highly active antiretroviral therapy.

Blackard JT, Yang Y, Bordoni P, Sherman KE, Chung RT; AIDS Clinical Trials Group 383 Study Team. Blackard JT, et al. Among authors: sherman ke. J Infect Dis. 2004 Apr 15;189(8):1472-81. doi: 10.1086/382959. Epub 2004 Mar 29. J Infect Dis. 2004. PMID: 15073685

8

Occult hepatitis B in HIV-infected patients.

Shire NJ, Rouster SD, Rajicic N, Sherman KE. Shire NJ, et al. Among authors: sherman ke. J Acquir Immune Defic Syndr. 2004 Jul 1;36(3):869-75. doi: 10.1097/00126334-200407010-00015. J Acquir Immune Defic Syndr. 2004. PMID: 15213572 Clinical Trial.

9

Complexity and diversity of hepatitis C virus RNA in african americans and whites: analysis of the envelope-coding domain.

Keenan ED, Rouster SD, Shire NJ, Horn PS, Sherman KE. Keenan ED, et al. Among authors: sherman ke. J Infect Dis. 2004 Aug 1;190(3):511-4. doi: 10.1086/421506. Epub 2004 Jul 7. J Infect Dis. 2004. PMID: 15243925

10

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.

Chung RT, Andersen J, Volberding P, Robbins GK, Liu T, Sherman KE, Peters MG, Koziel MJ, Bhan AK, Alston B, Colquhoun D, Nevin T, Harb G, van der Horst C; AIDS Clinical Trials Group A5071 Study Team. Chung RT, et al. Among authors: sherman ke. N Engl J Med. 2004 Jul 29;351(5):451-9. doi: 10.1056/NEJMoa032653. N Engl J Med. 2004. PMID: 15282352 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

266 results

Search Page